Key result
TB-402 emerges as a promising novel anticoagulant strategy for post-orthopaedic venous thromboembolism prevention.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Riva et al. (2013) studied this question. TB-402 is evaluated in an editorial discussing whether it represents a new and promising approach for the prevention of venous thromboembolism in orthopaedic surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: